Kidney cancer
Would you like to receive a message when there is new research about kidney cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you receive a notification as soon as new research on Renal cell carcinoma is published. View what Premium costs.
Publications and studies (2200)
- Computational and experimental pharmacology to decode the efficacy of Theobroma cacao L. against doxorubicin-induced organ toxicity in EAC-mediated solid tumor-induced mice. (2023/05/31) ♡
- Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy. (2023/05/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Food groups and urologic cancers risk: a systematic review and meta-analysis of prospective studies. (2023/05/17) ♡
- Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma. (2023/05/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis. (2023/05/07) ♡
- Investigating the differences in nutritional status between successfully weaned and unsuccessfully weaned respirator patients. (2023/05/02) ♡
- Genotype-phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions. (2023/05/01) ♡
- Evaluation of the Incidence of Pharyngocutaneous Fistula after Total Laryngectomy. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies. (2023/04/18) ♡
- A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma. (2023/04/17) ♡
- Radiofrequency ablation for renal tumours: A retrospective study from a tertiary centre. (2023/04/01) ♡
- Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States. (2023/04/01) ♡
- Nested Subtype of Urothelial Carcinoma in the Upper Urinary Tract: A Series of 15 Cases. (2023/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complete response to tislelizumab in a metastatic urothelial carcinoma after surgery associated with high tumor mutational burden: a case report. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A rapid review of patient-reported outcomes investigated in the context of advanced renal cell cancer or advanced hepatocellular cancer. (2023/04/01) ♡
- A new finding for the obesity paradox? Evaluation of the relationship between muscle and adipose tissue in nuclear grade prediction in patients with clear cell renal cell carcinoma. (2023/04/01) ♡
- Metastatic Renal Cell Carcinoma: An Enigmatic Nasal Mass. (2023/04/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review. (2023/04/01) ♡
- A comparison of analytic approaches for investigating the obesity paradox in kidney cancer. (2023/04/01) ♡
- Salvianolic acid A alleviates atherosclerosis by inhibiting inflammation through Trc8-mediated 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation. (2023/04/01) ♡
- Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018. (2023/04/01) ♡
- Cohort profile - the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands. (2023/03/27) ♡
- Clinical pathological characteristics and treatment outcomes of renal cell carcinoma (RCC): a retrospective study from Sudan. (2023/03/23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Investigating the association between fasting insulin, erythrocytosis and HbA1c through Mendelian randomization and observational analyses. (2023/03/17) ♡
- Histologic re-evaluation of a population-based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification. (2023/03/15) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer. (2023/03/14) ♡
- Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab. (2023/03/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Indications for and results of renal autotransplantation. (2023/03/01) ♡
- The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet? (2023/03/01) ♡
- Fumarate Hydratase and S-(2-Succinyl)-Cysteine Immunohistochemistry Shows Evidence of Fumarate Hydratase Deficiency in 2% of Uterine Leiomyosarcomas: A Cohort Study of 348 Tumors. (2023/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm. (2023/03/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis. (2023/03/01) ♡
- A Large Contemporary Experience of Renal Tumors in Young: Clinico-pathological Profile and Long-Term Survival Patterns. (2023/03/01) ♡
- Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma. (2023/03/01) ♡
- Transcription factor E3 renal cell carcinoma presenting as secondary hypertension. (2023/03/01) ♡
- Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma. (2023/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Clear evidence of the carcinogenic potential of anthracene: A 2-year feeding study in rats and mice. (2023/03/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature. (2023/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma. (2023/02/27) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Comparing efficacy and safety of first-line treatment of metastatic renal cell carcinoma: A Bayesian network meta-regression analysis. (2023/02/22) ♡
- [Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery]. (2023/02/18) ♡
- The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study. (2023/02/16) ♡
- Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. (2023/02/12) ♡
- Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy. (2023/02/03) ♡
- The potential of Lycium barbarum miR166a in kidney cancer treatment. (2023/02/01) ♡
- Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia. (2023/02/01) ♡
- Spectrum of germline and somatic mitochondrial DNA variants in Tuberous Sclerosis Complex. (2023/01/30) ♡
- Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. (2023/01/26) ♡
- Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy. (2023/01/25) ♡
- The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. (2023/01/19) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.